I haven't reviewed any clinical studies from Europe..yet. It really isn't about safety as I described earlier, its about efficacy (the potential to achieve desired results). From my knowledge about stem cells treatments for O.A. There would be more benefit potential for stem cell treatments for those patients that don't have severe O.A. (bone-on-bone). It comes down to triggering chondrocyte cell formation (cartilage cells) from stem cell injections. The goal is to repair focal zones of chondromalacia (thinning of cartilage) within the joint. Patients with moderate O.A. (a precursor to severe O.A.) is an example.
News 
Market Data 
Discover 
AI
